IP
MRK icon

Investment Partners’s Merck MRK Stock Holding History

Investment Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$599K Sell
4,977
-44
-0.9% -$5.08K 0.21% 96
2025
Q4 		$529K Buy
5,021
+103
+2% +$9.67K 0.19% 99
2025
Q3 		$413K Sell
4,918
-113
-2% -$9.31K 0.15% 112
2025
Q2 		$398K Sell
5,031
-158
-3% -$12.6K 0.15% 112
2025
Q1 		$466K Buy
5,189
+477
+10% +$44.5K 0.19% 99
2024
Q4 		$469K Sell
4,712
-1,488
-24% -$153K 0.19% 99
2024
Q3 		$704K Sell
6,200
-31
-0.5% -$3.68K 0.29% 81
2024
Q2 		$771K Sell
6,231
-123
-2% -$15.8K 0.35% 72
2024
Q1 		$838K Sell
6,354
-676
-10% -$83.3K 0.38% 69
2023
Q4 		$766K Buy
7,030
+234
+3% +$24.3K 0.38% 70
2023
Q3 		$700K Buy
6,796
+625
+10% +$67.4K 0.37% 71
2023
Q2 		$712K Sell
6,171
-955
-13% -$108K 0.37% 71
2023
Q1 		$758K Buy
7,126
+1,759
+33% +$190K 0.4% 71
2022
Q4 		$596K Sell
5,367
-12,626
-70% -$1.29M 0.31% 84
2022
Q3 		$1.55M Buy
17,993
+12,662
+238% +$1.13M 0.46% 63
2022
Q2 		$486K Buy
5,331
+265
+5% +$23.5K 0.24% 91
2022
Q1 		$416K Sell
5,066
-30
-0.6% -$2.37K 0.18% 99
2021
Q4 		$391K Buy
5,096
+18
+0.4% +$1.43K 0.16% 110
2021
Q3 		$381K Buy
5,078
+19
+0.4% +$1.45K 0.17% 106
2021
Q2 		$393K Buy
5,059
+861
+21% +$64K 0.18% 100
2021
Q1 		$309K Buy
4,198
+74
+2% +$5.46K 0.15% 119
2020
Q4 		$322K Sell
4,124
-451
-10% -$34.5K 0.17% 101
2020
Q3 		$362K Sell
4,575
-3,912
-46% -$306K 0.22% 86
2020
Q2 		$626K Buy
8,487
+957
+13% +$72K 0.37% 65
2020
Q1 		$553K Sell
7,530
-396
-5% -$31.1K 0.4% 64
2019
Q4 		$688K Sell
7,926
-105
-1% -$8.62K 0.46% 60
2019
Q3 		$645K Buy
8,031
+178
+2% +$14.3K 0.47% 60
2019
Q2 		$628K Sell
7,853
-296
-4% -$22.7K 0.45% 60
2019
Q1 		$647K Buy
8,149
+23
+0.3% +$1.72K 0.47% 62
2018
Q4 		$592K Buy
8,126
+22
+0.3% +$1.55K 0.5% 59
2018
Q3 		$370 Buy
8,104
+24
+0.3% +$1.53K 0.21% 74
2018
Q2 		$468K Sell
8,080
-1,544
-16% -$87.1K 0.35% 66
2018
Q1 		$500K Sell
9,624
-6,050
-39% -$327K 0.37% 68
2017
Q4 		$842K Buy
15,674
+443
+3% +$24.6K 0.62% 53
2017
Q3 		$931K Sell
15,231
-279
-2% -$16.9K 0.8% 41
2017
Q2 		$949K Buy
15,510
+133
+0.9% +$8.1K 0.86% 40
2017
Q1 		$932K Sell
15,377
-2,884
-16% -$175K 0.9% 41
2016
Q4 		$1.03M Sell
18,261
-14,564
-44% -$852K 1% 39
2016
Q3 		$1.96M Buy
32,825
+14,333
+78% +$838K 1.11% 30
2016
Q2 		$1.02M Sell
18,492
-13,129
-42% -$699K 1.01% 37
2016
Q1 		$1.59M Buy
31,621
+14,742
+87% +$722K 1.04% 33
2015
Q4 		$854K Sell
16,879
-289
-2% -$14.6K 1.03% 40
2015
Q3 		$813K Buy
17,168
+7,827
+84% +$416K 1.06% 38
2015
Q2 		$506K Buy
9,341
+1,165
+14% +$65.3K 0.61% 67
2015
Q1 		$446K Buy
8,176
+10
+0.1% +$566 0.49% 68
2014
Q4 		$443K Buy
+8,166
New +$455K 0.51% 66

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Investment Partners's MRK Position: Q1 2026 in Review

Investment Partners reduced its Merck (MRK) stake by 0.88% in Q1 2026, selling an estimated $5.08K and leaving 4,977 shares worth $599K. The position accounts for 0.21% of the portfolio, ranked #96.

Investment Partners first reported a position in MRK in Q4 2014 and has held it in 46 quarters since. The position peaked at $1.96M in Q3 2016. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Investment Partners held 4,977 shares of Merck worth $599K as of Q1 2026.
  • Investment Partners sold 44 Merck shares in Q1 2026, an estimated $5.08K.
  • Merck made up 0.21% of Investment Partners's portfolio in Q1 2026, its #96 holding.
  • Investment Partners first reported a position in Merck in Q4 2014 and has held it in 46 quarters since.
  • Investment Partners's Merck position peaked at $1.96M in Q3 2016.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Investment Partners's 13F filing for Q1 2026, filed 5 May 2026.